| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.55 | 0.0002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0007 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.1 | 0.008 |